CHRISTOPHER PARK: Open Payments
NPI 1710181078 · PONTOTOC, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 13 payments from 7 companies in 2025. Trend: 2023 $350 · 2024 $311 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| ABBVIE INC. | 2 | $33 |
| PFIZER INC. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| Indivior Inc. | 1 | $16 |
Products named: CAPLYTA, BREZTRI, VRAYLAR, NURTEC ODT, Veozah, SUBLOCADE.
Industry payments across MS — which companies pay providers there.
